Observational Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Jun 14, 2022; 28(22): 2494-2508
Published online Jun 14, 2022. doi: 10.3748/wjg.v28.i22.2494
Table 3 Receiver operating characteristic analysis on the histopathology unblinded test group and histopathology blinded test group cohorts for diagnosing steatosis grades

HP-U
HP-T
View
n
AUC5%
AUC33%
AUC66%
Acc
n
AUC5%
AUC33%
AUC66%
Acc
Complete 4 view group study1
LLL410.98 (0.93, 1.00)0.95 (0.89, 1.00)0.94 (0.87, 1.00)83%510.90 (0.82, 0.98)0.92 (0.81, 1.00)0.90 (0.82, 0.99)88%
RLL410.96 (0.90, 1.00)0.95 (0.89, 1.00)0.89 (0.79, 0.99)85%510.84 (0.73, 0.95)0.93 (0.84, 1.00)0.92 (0.85, 1.00)96%
LKC410.96 (0.90, 1.00)0.95 (0.89, 1.00)0.93 (0.84, 1.00)83%510.84 (0.73, 0.95)0.95 (0.90, 1.00)0.88 (0.79, 0.97)90%
SC410.96 (0.90, 1.00)0.92 (0.84, 1.00)0.89 (0.79, 0.99)83%510.88 (0.79, 0.97)0.93 (0.86, 1.00)0.88 (0.77, 0.99)90%
All view groups410.96 (0.90, 1.00)0.94 (0.88, 1.00)0.92 (0.83, 1.00)83%510.88 (0.79, 0.98)0.95 (0.88, 1.00)0.91 (0.83, 0.99)94%
Individual view group study1
LLL1030.95 (0.90, 0.99)0.93 (0.87, 0.98)0.91 (0.86, 0.97)80%960.84 (0.76, 0.93)0.92 (0.85, 0.99)0.93 (0.88, 0.98)90%
RLL1380.94 (0.91, 0.98)0.91 (0.86, 0.98)0.85 (0.78, 0.92)83%1090.82 (0.74, 0.90)0.89 (0.83, 0.96)0.92 (0.87, 0.97)92%
LKC880.96 (0.92, 1.00)0.92 (0.86, 0.98)0.84 (0.76, 0.92)80%710.81 (0.69, 0.93)0.93 (0.87, 0.99)0.89 (0.81, 0.96)90%
SC1170.93 (0.89, 0.98)0.91 (0.85, 0.96)0.86 (0.79, 0.92)79%900.86 (0.77, 0.94)0.89 (0.82, 0.96)0.90 (0.83, 0.97)88%
All view groups1470.95 (0.91, 0.98)0.92 (0.88, 0.96)0.87 (0.81, 0.92)76%1120.85 (0.77, 0.93)0.91 (0.85, 0.97)0.93 (0.88, 0.98)90%
FibroScan comparison study1,2
All view groups1470.953 (0.92, 0.98)0.953 (0.92, 0.98)0.923 (0.88, 0.97)77%800.93 (0.87, 0.98)0.97 (0.93, 1.00)0.923 (0.86, 0.98)91%
FibroScan1470.88 (0.81, 0.95)0.88 (0.81, 0.95)0.80 (0.73, 0.87)62%800.89 (0.82, 0.96)0.92 (0.86, 0.98)0.82 (0.73, 0.92)68%